Adipo Therapeutics has successfully completed a $1.9 million seed funding bridge to advance obesity and Type 2 diabetes treatment. The company will embark on raising $35M Series A financing.

Vision Tech Partners

Iu Ventures

Elevate Ventures

Purdue Research Foundation

Adipo Therapeutics, an Indiana biotechnology company, is developing polymer-based, Notch-inhibiting nanoparticles that are injected directly into adipose (fat) tissue to induce browning, or white-to-beige adipocyte transformation. 

adipotherapeutics.com

Biopharma

Therapeutics

Health Care

Biotechnology

Indianapolis

Adipo Therapeutics

Adipo Therapeutics completes $1.9M seed funding bridge to advance obesity and Type 2 diabetes treatment

Adipo Therapeutics completes $1.9M seed funding bridge to advance obesity and Type 2 diabetes treatment

Investors

Description

Company Information

Related People

Funding Insights

Adipo Therapeutics completes $1.9M seed funding bridge to advance obesity and Type 2 diabetes treatment

Investors

Description

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Related People

Funding Insights

Company Information